US support for waiving COVID-19 vaccine patent rights puts pressure on drugmakers – but what would a waiver actually look like?

The process will take months, if it's even approved. But just the threat of waiving intellectual property rights could spur faster action.

© La Conversation - lundi 10 mai 2021